Riverbridge Partners LLC Reduces Position in Roche Holding AG (OTCMKTS:RHHBY)

Riverbridge Partners LLC reduced its position in Roche Holding AG (OTCMKTS:RHHBY) by 12.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,445 shares of the company’s stock after selling 5,271 shares during the quarter. Riverbridge Partners LLC’s holdings in Roche were worth $1,236,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of RHHBY. Kornitzer Capital Management Inc. KS boosted its position in Roche by 1.3% in the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 136,923 shares of the company’s stock valued at $5,490,000 after buying an additional 1,798 shares during the period. Bard Financial Services Inc. raised its stake in shares of Roche by 37.7% during the fourth quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock valued at $3,866,000 after acquiring an additional 30,350 shares in the last quarter. Diversified Trust Co boosted its holdings in shares of Roche by 1.2% in the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock valued at $2,130,000 after purchasing an additional 711 shares during the period. Norman Fields Gottscho Capital Management LLC grew its stake in Roche by 5.5% in the third quarter. Norman Fields Gottscho Capital Management LLC now owns 26,000 shares of the company’s stock worth $1,039,000 after purchasing an additional 1,350 shares in the last quarter. Finally, Confluence Investment Management LLC increased its holdings in Roche by 26.3% during the 4th quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock worth $488,000 after purchasing an additional 2,910 shares during the period.

Roche Stock Up 1.0 %

Shares of RHHBY stock opened at $37.85 on Thursday. The company has a current ratio of 1.26, a quick ratio of 0.97 and a debt-to-equity ratio of 0.86. Roche Holding AG has a twelve month low of $29.20 and a twelve month high of $42.43. The stock has a fifty day simple moving average of $35.76 and a two-hundred day simple moving average of $38.10.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.